Approximately 80 percent of patients who have the hepatitis C virus may have been missed through EMR-reliant risk-based testing, according to research from the CDC. The paper, published in Clinical ...
A study found that a blood test detecting ctDNA after surgery more accurately predicts recurrence and survival in patients with stage 3 colon cancer.
University of California, San Francisco investigators led WISDOM, a randomized comparison of risk-based breast cancer screening and annual mammography. Rates of stage ≥IIB breast cancers met a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results